What is Gain Therapeutics Inc?
, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company's drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 44.50M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.